Cargando…

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy

BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therapy in patients with HIV-1 infection, there are no evidence-based recommendations regarding its optimal frequency. It is common practice to monitor every 3 to 6 months, often coupled with viral load mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buclin, Thierry, Telenti, Amalio, Perera, Rafael, Csajka, Chantal, Furrer, Hansjakob, Aronson, Jeffrey K., Glasziou, Paul P.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072996/ https://www.ncbi.nlm.nih.gov/pubmed/21494630 http://dx.doi.org/10.1371/journal.pone.0018578

Ejemplares similares

Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy
por: Barceló, Catalina, et al.
Publicado: (2020)

Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
por: Courlet, Perrine, et al.
Publicado: (2021)

Tobramycin exposure from active calcium sulfate bone graft substitute
por: Livio, Françoise, et al.
Publicado: (2014)

Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
por: Glass, Tracy R., et al.
Publicado: (2012)

From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
por: Goutelle, Sylvain, et al.
Publicado: (2023)

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
por: Goutelle, Sylvain, et al.
Publicado: (2022)

The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
por: Buclin, Thierry, et al.
Publicado: (2020)

Development and validation of a multiplex UHPLC‐MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre
por: Jermini, Mégane, et al.
Publicado: (2019)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
por: Chammartin, Frédérique, et al.
Publicado: (2022)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

Clinical use of pharmacogenomics
por: Telenti, Amalio
Publicado: (2012)

HIV-1 host interactions: integration of large-scale datasets
por: Telenti, Amalio
Publicado: (2009)

Host genome influences on susceptibility to HIV-1
por: Telenti, Amalio
Publicado: (2009)

Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition
por: Mossdorf, Erik, et al.
Publicado: (2011)

Impact of Pharmaceutical Interventions with STOPP/START and PIM-Check in Older Hospitalized Patients: A Randomized Controlled Trial
por: Farhat, Akram, et al.
Publicado: (2022)

Innate immunogenetics: a tool for exploring new frontiers of host defence
por: Bochud, Pierre-Yves, et al.
Publicado: (2007)

Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
por: Riebensahm, Carlotta, et al.
Publicado: (2022)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs
Publicado: (2018)

Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
por: Thoueille, Paul, et al.
Publicado: (2021)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

Frequency of adverse events associated to antiretroviral drugs in patients starting therapy in Salvador, Brazil
por: Vendruscolo, Ornela, et al.
Publicado: (2014)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018)

Genetic screening for metabolic and age-related complications in HIV-infected persons
por: Tarr, Philip E, et al.
Publicado: (2010)

Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007
por: Ballif, Marie, et al.
Publicado: (2009)

Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared
por: Keiser, Olivia, et al.
Publicado: (2008)

Correction: Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared
por: Keiser, Olivia, et al.
Publicado: (2008)

A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011)

Single-Cell Genomics for Virology
por: Ciuffi, Angela, et al.
Publicado: (2016)

Sincell: an R/Bioconductor package for statistical assessment of cell-state hierarchies from single-cell RNA-seq
por: Juliá, Miguel, et al.
Publicado: (2015)

Innate immune defects in HIV permissive cell lines
por: Rausell, Antonio, et al.
Publicado: (2016)

Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trials
por: Schechter, Mauro
Publicado: (2018)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

Imatinib plasma levels: correlation with clinical benefit in GIST patients
por: Widmer, N, et al.
Publicado: (2010)

Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy
por: Stuehler, Claudia, et al.
Publicado: (2016)

Ten Simple Rules for Starting a Company
por: Fletcher, Anthony C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2gnocs7jmb61l8ap22r0p2in4l